The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

AmSurg Corp

Nasdaq: AMSG
Last

(U.S.) $61.67

Today's change-0.31 -0.50%
Updated March 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

AmSurg Corp

Nasdaq: AMSG
Last

(U.S.) $61.67

Today's change-0.31 -0.50%
Updated March 27 4:00 PM EDT. Delayed by at least 15 minutes.

AmSurg Corp crosses below 20-day moving average

AmSurg Corp closed lower Friday, dropping (U.S.)$0.31 or 0.50% to (U.S.)$61.67 and crossing below its 20-day moving average. Shares have lost 3.67% over the last five days, but have gained 12.68% over the last year to date. This security has outperformed the S&P 500 by 21.96% during the last year.

Key company metrics

  • Open(U.S.) $61.88
  • Previous close(U.S.) $61.98
  • High(U.S.) $62.26
  • Low(U.S.) $61.11
  • Bid / Ask-- / --
  • YTD % change+12.68%
  • Volume373,620
  • Average volume (10-day)434,557
  • Average volume (1-month)484,875
  • Average volume (3-month)446,431
  • 52-week range(U.S.) $40.00 to (U.S.) $65.03
  • Beta1.09
  • Trailing P/E52.98×
  • P/E 1 year forward18.97×
  • Forward PEG0.98×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.16
Updated March 27 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+15.17%

Based on its net profit margin of 15.17%, AmSurg Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.39%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue579503281263
Total other revenue--------
Total revenue579503281263
Gross profit536461240224
Total cost of revenue43424139
Total operating expense448408193183
Selling / general / administrative2932668583
Research & development--------
Depreciation / amortization232198
Interest expense (income), net operating--------
Unusual expense (income)00-1-2
Other operating expenses, total93826055
Operating income132958880
Interest income (expense), net non-operating-30-39-7-7
Gain (loss) on sale of assets--------
Other--------
Income before tax101398173
Income after tax79396860
Income tax, total2201313
Net income27-101917
Total adjustments to net income-2-2----
Net income before extra. items27-81918
Minority interest-52-47-49-43
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items25-101918
Inc. avail. to common incl. extra. items25-121917
Diluted net income25-121917
Dilution adjustment0000
Diluted weighted average shares47463232
Diluted EPS excluding extraordinary itemsvalue per share0.53-0.220.590.54
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.53-0.220.550.49